epitopebas
dna
vaccin
design
induc
cell
respons
specif
mycobacterium
tuberculosi
tb
develop
mean
address
vaccin
potenc
studi
predict
cell
epitop
antigen
construct
ecan
epitop
cast
natur
structur
dna
vaccin
insert
epitop
dna
segment
separ
gene
backbon
tbderiv
heat
shock
protein
carrier
immunogen
protect
efficaci
pecan
dna
vaccin
assess
balbc
mice
intramuscular
immun
dose
g
ecan
dna
follow
mycobateri
challeng
week
last
immun
compar
plasmid
encod
pecan
dna
immun
elicit
remark
higher
level
product
cell
coupl
higher
frequenc
antigenspecif
cell
higher
ctl
activ
significantli
enhanc
level
cytokin
increas
serum
ratio
also
note
indic
predomin
immun
respons
achiev
pecan
dna
immun
consequ
better
protect
mycobacterium
bovi
bcg
challeng
achiev
evidenc
reduc
bacteri
load
lung
spleen
profound
attenu
lung
inflamm
injuri
result
suggest
multit
cellepitop
base
ecan
gene
vaccin
induc
cell
respons
multipl
cell
epitop
led
enhanc
protect
mycobacteri
challeng
strategi
might
use
platform
design
multit
cell
epitopebas
vaccin
tb
infect
tuberculosi
tb
remain
singl
largest
infecti
diseas
lead
caus
death
throughout
world
account
death
everi
minut
million
death
annual
sever
threat
health
humankind
present
avail
tb
vaccin
attenu
strain
mycobacterium
bovi
bacillu
bcg
although
effect
prevent
mycobacterium
tuberculosi
tb
infect
newborn
toddler
bcg
provid
poor
protect
adult
pulmonari
tuberculosi
vari
protect
efficaci
preexposur
environment
mycobacteria
may
prevent
mask
bcginduc
protect
immun
addit
protect
efficaci
bcg
weaken
continu
attenu
loss
immunodomin
antigen
antigen
protein
therefor
altern
prevent
tb
vaccin
urgent
need
wellknown
cell
play
primari
role
protect
immun
respons
tb
howev
search
suitabl
antigen
elicit
potent
cell
immun
respons
thwart
complex
tb
proteom
vaccin
base
cell
epitop
repres
ideal
approach
gener
effect
cellular
immun
prophylact
therapeut
set
multipl
epitop
incorpor
one
vaccin
induc
broadli
immun
respons
react
variou
immunogen
epitop
present
absent
bcg
epitop
highli
conserv
among
bacteri
type
domin
epitop
numer
gene
product
could
preferenti
select
furthermor
immun
respons
would
restrict
specif
epitop
requir
type
protect
immun
respons
would
gener
overcom
potenti
safeti
concern
associ
vaccin
regimen
develop
epitopebas
vaccin
hamper
rel
low
antigen
thu
differ
vaccin
format
deliveri
methodolog
util
includ
dna
vaccin
viral
vector
protein
carrier
solv
problem
mutictl
epitop
dna
vaccin
report
induc
broad
ctl
respons
hiv
hbv
sarscov
introduct
heterolog
epitop
protein
carrier
genet
engin
synthet
coupl
method
enhanc
immun
respons
induc
potent
humor
cellmedi
immun
respons
promot
epitop
spread
mycobacteri
heat
shock
protein
hsp
chaperon
protein
receiv
immens
attent
suitabl
safe
protein
carrier
consider
instinct
helper
epitop
abil
chaperon
antigen
peptid
facilit
crosspresent
apc
demonstr
bcgderiv
capabl
deliv
antigen
peptid
mhc
class
present
pathway
apc
thu
stimul
antigenspecif
tcell
respons
also
use
deliv
b
cell
epitop
absenc
adjuv
besid
dna
vaccin
encod
protect
mice
virul
strain
tb
challeng
exhibit
cure
effect
indic
immunodomin
tb
antigen
therefor
select
carrier
incorpor
multipl
epitop
immunodomin
antigen
tb
studi
predict
cell
epitop
welldefin
tb
protect
antigen
earli
secretori
antigen
cell
cultur
filtrat
protein
via
epitop
predict
softwar
onlin
epitopeencod
gene
graft
variou
interdomain
region
scaffold
gene
obtain
multiepitop
dna
vaccin
design
ecan
epitop
cast
natur
structur
intramuscular
immun
dna
vaccin
perform
evalu
efficaci
induc
specif
protect
immun
respons
mycobacteri
tuberculosi
potenti
mhc
ior
iibind
cell
epitop
screen
protein
use
epitop
predict
softwar
onlin
http
wwwsyfpeithicom
scriptsmhcsrdllhomehtm
http
wwwjenneracukmhcpr
http
wwwimtechresinraghavapropr
similar
score
use
positionspecif
score
matrix
deriv
align
peptid
four
epitop
includ
elnnalqnlarti
glsmaassaltl
vvrfqeaankqkqel
qqfiyagslsal
sort
tbderiv
dna
fragment
yield
genom
pcr
use
forward
primer
gaagaattcatggccaagaca
revers
primer
insert
invitrogen
gener
plasmid
select
cell
epitop
engin
scaffold
separ
except
separ
one
anoth
aay
spacer
fig
chimera
ecan
gene
yield
method
gene
splice
overlap
extens
sever
synthet
nucleotid
sequenc
incorpor
plasmid
driven
cmv
promot
bcg
purifi
protein
deriv
ppd
purchas
shanghai
institut
biolog
product
recombin
protein
express
histag
protein
escherichia
coli
express
system
novagen
purifi
previous
describ
polypeptid
commerci
synthes
gl
biochem
ltd
shanghai
puriti
dissolv
pb
store
c
use
six
eight
week
femal
balbc
mice
purchas
experiment
anim
centr
chines
academi
scienc
shanghai
pr
china
remain
pathogenfre
condit
anim
experi
perform
accord
guidelin
care
use
laboratori
anim
ministri
health
pr
china
guidelin
laboratori
anim
ethic
commiss
fudan
univers
endotoxinfre
plasmid
prepar
use
endofre
plasmid
purif
mega
prep
kit
qiagen
mice
immun
intramuscularli
g
pecan
time
biweekli
serum
collect
week
final
immun
retroorbit
bleed
store
c
analysi
cell
transfect
pecan
lipofectamin
invitrogen
cultur
h
supernat
electrophores
sdspage
gel
transfer
pvdf
membran
membran
probe
mab
santa
cruz
follow
horseradish
peroxidas
hrp
conjug
goat
antimous
antibodi
southernbiotech
signal
develop
use
chemiluminesc
amersham
bioscienc
plate
coat
ppd
protein
predict
peptid
final
concentr
gml
c
overnight
block
bsapb
serum
dilut
ad
duplic
hrpconjug
goat
antimous
igg
southernbiotech
ad
follow
opd
substrat
addit
absorb
nm
measur
micropl
reader
biolab
elispot
perform
elispot
assay
kit
bd
pharmingen
briefli
plate
coat
captur
mab
overnight
c
block
complet
media
h
room
temperatur
splenocyt
immun
mice
isol
plate
cellswel
cultur
predict
peptid
pool
peptid
protein
ppd
inactiv
final
concentr
gml
c
h
wash
plate
deioniz
water
pbst
biotinyl
mab
ad
h
room
temperatur
plate
supplement
streptavidinalkalin
phosphatas
h
color
develop
apcolorimetr
substrat
immunospot
analyz
cellular
technolog
use
enumer
spot
splenocyt
immun
mice
plate
cellswel
cultur
mix
peptid
inactiv
gml
h
concentr
cultur
supernat
measur
elisa
kit
r
follow
manufactur
procedur
two
week
final
immun
splenocyt
isol
stain
antibodi
bd
pharmingen
wash
cell
treat
fixationpermeabil
solut
bd
pharmingen
min
c
stain
antibodi
bd
pharmingen
percentag
cell
determin
flow
cytometri
use
facscalibur
instrument
bd
bioscienc
vivo
ctl
assay
perform
describ
earlier
briefli
week
final
immun
mice
adopt
transfer
cell
mix
unpulsedcfs
low
peptidespulsedcfs
high
syngen
target
cell
peptid
use
puls
target
cell
pool
predict
peptid
h
later
adopt
transfer
mice
kill
splenocyt
isol
resuspend
pb
acquisit
facscalibur
instrument
bd
bioscienc
evalu
percentag
specif
lysi
ratio
cfse
high
cfse
low
vaccin
mice
compar
ratio
transfer
naiv
control
mice
bcg
denmark
strain
grown
middlebrook
broth
supplement
middlebrook
oadc
enrich
bd
pharmingen
glycerol
tween
day
aliquot
store
c
use
bacteria
wash
pb
contain
tween
twice
pass
needl
time
dispers
clump
immun
mice
infect
intranas
cfu
bcg
week
postimmun
level
bacteri
burden
determin
week
postchalleng
lung
spleen
plate
serial
dilut
tissu
homogen
triplic
onto
middlebrook
agar
plate
plate
incub
week
c
coloni
count
calcul
present
log
cfu
per
organ
lung
tissu
harvest
histolog
evalu
week
bcg
challeng
fix
buffer
formalin
embed
paraffin
section
stain
hematoxylin
eosin
analyz
pathologist
blind
treatment
alloc
score
lung
inflamm
damag
entir
lung
section
analyz
confluent
inflammatori
infiltr
quantifi
express
percentag
lung
surfac
data
given
mean
sd
statist
analysi
data
perform
twotail
independ
student
ttest
analysi
use
spss
version
spss
inc
p
consid
statist
signific
design
multival
dna
vaccin
tb
protein
sequenc
screen
cell
epitop
use
epitop
predict
softwar
onlin
polypeptid
chosen
base
score
accord
syfpeithi
mhcpred
softwar
analysi
overlap
bind
cell
epitop
ia
bind
cell
epitop
four
polypeptid
among
qqfiyagslsal
glsmaassaltl
seem
harbor
cell
epitop
higher
mhcbind
score
two
polypeptid
depend
function
domain
threedimension
structur
protein
cell
epitop
graft
interdomain
scaffold
constitut
ecan
chimera
gene
place
construct
plasmid
design
pecan
fig
verifi
transcript
effici
vitro
lipofectamineaid
transfect
assay
conduct
cell
western
blot
assay
show
kda
protein
kda
protein
present
cell
lysi
accord
molecular
weight
ecan
protein
indic
plasmid
effici
express
vitro
fig
assess
engin
would
influenc
abil
induc
antibodi
femal
balbc
mice
vaccin
intramuscularli
g
pecan
time
biweekli
two
week
final
immun
level
serum
igg
specif
rang
defin
mycobacteri
antigen
ppd
detect
elisa
assay
shown
fig
high
level
igg
specif
ppd
protein
detect
pecansimmun
mice
od
valu
reach
respect
indic
induct
specif
humor
immun
howev
seem
lower
elicit
vaccin
od
valu
equal
p
igg
subclass
concern
significantli
elev
ratio
observ
follow
pecan
immun
indic
cast
cell
epitop
scaffold
impair
abrog
immunogen
gener
tbspecif
antibodi
meanwhil
respons
initi
strategi
cell
play
critic
role
protect
immun
mycobacteri
infect
elispot
assay
perform
splenocyt
isol
immun
mice
week
final
immun
analyz
whether
pecan
induc
specif
cell
respons
shown
fig
pecan
inject
gener
significantli
increas
number
cell
separ
respond
inactiv
ppd
protein
comparison
mice
treat
p
suggest
pecan
immun
markedli
augment
splenic
function
cell
respons
meanwhil
magnitud
singl
epitopespecif
cell
respons
evalu
compar
demonstr
epitop
within
pecan
effect
induc
specif
secret
cell
fig
immunogen
epitop
consist
predict
mhc
bind
score
epitopespecif
cell
achiev
investig
contribut
cell
intracellular
cytokin
stain
assay
perform
consist
elispot
data
compar
respons
immun
fig
splenic
cell
specif
mix
epitop
peptid
evidenc
follow
pecan
inject
frequenc
cell
specif
inactiv
increas
pecan
immun
mice
remark
higher
mice
p
fig
indic
multiepitop
cast
strategi
effect
enhanc
tbspecif
cell
respons
concurr
singl
use
dna
vaccin
assess
cytolyt
function
pecansinduc
antigenspecif
cell
vivo
cytotox
assay
perform
cfselabel
splenocyt
naiv
mice
unpuls
puls
pool
mix
cell
epitop
adopt
transfer
immun
mice
epitopespecif
lysi
transfer
cell
investig
flow
cytometr
analysi
compar
low
level
kill
detect
control
mice
fig
significantli
increas
lysi
observ
spleen
mice
receiv
pecan
p
indic
greatli
enhanc
tbspecif
ctl
activ
achiev
pecan
immun
increas
frequenc
cell
intramuscular
immun
pecan
two
week
follow
final
immun
splenocyt
collect
stimul
pool
epitop
inactiv
b
h
percentag
cell
analyz
flow
cytometri
individu
experi
conduct
three
time
one
repres
shown
group
significantli
enhanc
serum
ctl
activ
pecan
immun
indic
induct
immun
respons
cytokin
profil
produc
lymphocyt
specif
stimul
analyz
shown
fig
level
cytokin
supernat
splenocyt
significantli
higher
pecansimmun
mice
mice
p
level
cytokin
less
pecanstr
mice
confirm
promot
immun
respons
determin
protect
potenti
pecan
vaccin
week
final
immun
mice
intranas
challeng
cfu
bcg
bacteri
burden
lung
spleen
well
patholog
pulmonari
injuri
examin
week
postchalleng
shown
fig
b
immunizafig
tbspecif
ctl
activ
elicit
pecan
unpuls
splenocyt
cfse
low
peptidespuls
splenocyt
cfse
high
naiv
mice
transfer
immun
mice
percentag
repres
histogram
b
splenic
tbspecif
lysi
immun
mice
compar
data
one
repres
experi
three
perform
present
mean
sd
n
p
tion
provid
modest
level
protect
bcg
challeng
reduct
bacteria
burden
calcul
log
cfu
reduct
lung
spleen
respect
contrast
pecan
immun
significantli
increas
protect
give
signific
reduct
bacteria
lung
log
cfu
spleen
log
cfu
demonstr
tbspecif
immun
respons
elicit
intramuscular
inject
pecan
led
enhanc
host
defens
local
system
tissu
compart
tissu
patholog
observ
seen
lung
tissu
mock
mice
show
widespread
sever
interstiti
pneumonia
intens
inflamm
diffus
granuloma
respons
bcg
infect
display
larg
cluster
lymphocyt
macrophag
infiltr
fig
mice
immun
show
moder
damag
alveolar
tissu
rel
fewer
lymphocyt
infiltr
smaller
granuloma
mice
given
pecan
immun
intact
alveolar
tissu
mild
lung
inflamm
indic
dramat
attenu
tuberculosi
patholog
histolog
evid
togeth
bacteri
burden
reduct
corrobor
protect
effect
achiev
multiepitopebas
pecan
dna
immun
great
progress
achiev
develop
novel
tb
vaccin
use
variou
regimen
attenu
live
inactiv
whole
bacterium
subunit
vaccin
dna
vaccin
compar
convent
vaccin
platform
dna
vaccin
repres
novel
approach
good
gener
cell
respons
hold
number
advantag
includ
safeti
stabil
well
eas
prepar
manipul
dna
vaccin
preferenti
gener
ctl
immun
respons
may
play
meaning
role
elimin
intracellular
pathogen
includ
tb
develop
tb
dna
vaccin
benefit
tremend
sequenc
tb
genom
acceler
identif
novel
protect
antigen
tb
dna
vaccin
report
compar
protect
effici
mice
tb
infect
bcg
current
step
process
clinic
trial
highlight
promis
potenti
new
gener
tb
vaccin
select
appropri
antigen
prerequisit
design
tb
dna
vaccin
howev
criterion
antigen
select
remain
vagu
due
complex
host
immun
respons
vast
repertoir
tb
proteom
approxim
protein
secret
tb
antigen
prove
induc
stronger
immun
respons
cytosol
protein
human
complex
constitut
protein
also
import
involv
synthesi
tb
cell
wall
dna
vaccin
encod
stimul
strong
cellmedi
immun
respons
confer
signific
protect
aerosol
intraven
challeng
live
indic
signific
addit
protein
lack
bcg
strain
present
patholog
tb
identifi
potent
cell
antigen
anim
human
strongli
recogn
first
memori
phase
tb
infect
ad
delet
antigen
back
tb
vaccin
respect
import
strategi
improv
effect
tb
vaccin
therefor
studi
tri
identifi
multipl
previous
uncharacter
cell
epitop
antigen
cast
integr
multipl
cell
epitop
immunogen
carrier
achiev
best
protect
effect
demonstr
multiepitop
dna
vaccin
effici
elicit
potent
cell
immun
system
lymphoid
organ
gave
signific
protect
mycobacteri
challeng
evidenc
greatli
reduc
bacteri
burden
lung
patholog
despit
progress
understand
immun
protect
factor
tb
infect
induct
cell
remain
cornerston
protect
immun
evid
correl
studi
indic
presenc
function
cell
may
associ
improv
clinic
outcom
human
tuberculosi
cytokin
appear
also
necessari
control
growth
tb
establish
protect
immun
respons
anim
human
defici
result
higher
suscept
tb
infect
current
studi
significantli
higher
cell
respons
whether
inactiv
mix
epitop
elicit
pecansimmun
vaccin
cell
contribut
product
cell
meanwhil
robust
ctl
respons
notic
indic
induct
integr
cell
immun
respons
pecan
strikingli
higher
amount
lower
amount
observ
pecansimmun
mice
suggest
predomin
immun
respons
altogeth
ctl
well
cytokin
account
ideal
protect
effect
seen
pecan
immun
mice
summari
assess
feasibl
immunolog
efficaci
multiepitopebas
dna
vaccin
tb
intramuscular
immun
pecan
predominantli
induc
tbspecif
immun
respons
ctl
activ
confer
enhanc
protect
mycobacteri
infect
strategi
might
help
design
dna
vaccin
control
tb
infect
